← back to search

Tan Trinh

University of Houston · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Chimeric antigen receptor, Cytokine release syndrome, Oncology, and CD28.
h-index
citations
45
works
1
NIH funding
primary concept
email

Recent publications

Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)
Blood Cancer Discovery 2023cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xavier Poiré · Cliniques Universitaires Saint-Luc1 papers (2023–2023)Justin A. Budka · Indiana University School of Medicine1 papers (2023–2023) · 1 papers (2023–2023)Miguel Canales · Navarre Institute of Health Research1 papers (2023–2023) · 1 papers (2023–2023)Ethan G. Aguilar · University of California, Davis1 papers (2023–2023)Adrian Bot · Centre Hospitalier Universitaire de Rennes1 papers (2023–2023)Saran Vardhanabhuti · Gilead Sciences (Australia)1 papers (2023–2023)Lazaros J. Lekakis · Case Western Reserve University1 papers (2023–2023)Rhine R. Shen · Kite (United States)1 papers (2023–2023)Sven de Vos · APLA Health1 papers (2023–2023)Justin Chou · Eureka Therapeutics (United States)1 papers (2023–2023)Marco Schupp · Integrated BioTherapeutics (United States)1 papers (2023–2023) · 1 papers (2023–2023)Jason R. Westin · The University of Texas MD Anderson Cancer Center1 papers (2023–2023)Craig A. Portell · MACOM (United States)1 papers (2023–2023)Soumya Poddar · Gilead Sciences (Australia)1 papers (2023–2023)Carmen M. Warren · Aadi (United States)1 papers (2023–2023)Simone Filosto · Gilead Sciences (United Kingdom)1 papers (2023–2023)